HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Maddalena Cavalluzzi Selected Research

Paclitaxel (Taxol)

11/2022Lubeluzole Repositioning as Chemosensitizing Agent on Multidrug-Resistant Human Ovarian A2780/DX3 Cancer Cells.
9/2013A convenient synthesis of lubeluzole and its enantiomer: evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Maddalena Cavalluzzi Research Topics

Disease

4Myotonia
07/2023 - 02/2013
3Neoplasms (Cancer)
11/2022 - 06/2016
2Pain (Aches)
02/2023 - 01/2018
2Inflammation (Inflammations)
01/2023 - 01/2021
2Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 05/2022
2Carcinoma (Carcinomatosis)
06/2016 - 09/2013
2Adenocarcinoma
06/2016 - 09/2013
1Cardiotoxicity
02/2023
1Mental Disorders (Mental Disorder)
02/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
11/2022
1Lung Neoplasms (Lung Cancer)
11/2022
1Neuroblastoma
11/2022
1Diarrhea
02/2021
1Reperfusion Injury
01/2021
1Wounds and Injuries (Trauma)
12/2020
1Infections
09/2020
1COVID-19
04/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Trigeminal Neuralgia (Tic Douloureux)
01/2018
1Tinnitus
01/2018
1Neuralgia (Stump Neuralgia)
01/2018
1Myotonic Disorders (Paramyotonia Congenita)
01/2018
1Long QT Syndrome
01/2018
1Ischemic Stroke
01/2018
1Cardiac Arrhythmias (Arrythmia)
07/2013
1Chronic Pain
02/2013
1Epilepsy (Aura)
02/2013

Drug/Important Bio-Agent (IBA)

5lubeluzoleIBA
11/2022 - 09/2013
3Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2021
2Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2023 - 05/2022
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 09/2013
2Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 09/2013
2AntioxidantsIBA
11/2022 - 01/2021
2Tocainide (Tonocard)FDA Link
12/2021 - 01/2018
2Sodium Channel BlockersIBA
12/2021 - 02/2013
2Mexiletine (Mexitil)FDA LinkGeneric
01/2021 - 07/2013
1RiluzoleFDA LinkGeneric
07/2023
1EndocannabinoidsIBA
02/2023
1Biomarkers (Surrogate Marker)IBA
02/2023
1Antipsychotic Agents (Antipsychotics)IBA
02/2023
1CDAA (Randox)IBA
01/2023
1LipidsIBA
01/2023
1SolventsIBA
11/2022
1Free RadicalsIBA
11/2022
1FlavonoidsIBA
11/2022
12,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
11/2022
1Mitochondrial RNAIBA
05/2022
1Anti-Bacterial Agents (Antibiotics)IBA
02/2021
1Cardiotonic Agents (Cardiac Stimulants)IBA
01/2021
1GlycosidesIBA
01/2021
1EstersIBA
01/2021
1PatulinIBA
12/2020
1Chloroquine (Aralen)FDA LinkGeneric
04/2020
1Lysophosphatidic Acid ReceptorsIBA
01/2020
1benzothiazoleIBA
01/2018
1Neuroprotective AgentsIBA
06/2016
1Vasodilator Agents (Vasodilators)IBA
07/2013
1Protein Isoforms (Isoforms)IBA
02/2013

Therapy/Procedure

1Catheters
09/2020
1Drug Therapy (Chemotherapy)
02/2013